









市场行情
/
股票
/
nasdaq-tech
/

Bio-Techne Corp

TECH

65.700USD

+1.120+1.73%

收盘 01/09, 16:00（美东）报价延迟15分钟

10.23B总市值

131.56市盈率 TTM



Bio-Techne Corp

65.700

+1.120+1.73%

概览公司财务分析

概览

公司

财务

分析

关于 Bio-Techne Corp 公司

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp简介



公司代码TECH

公司名称Bio-Techne Corp

上市日期Feb 09, 1989

CEOKelderman (Kim)

员工数量3100

证券类型Ordinary Share

年结日Feb 09

公司地址614 Mckinley Pl N E

城市MINNEAPOLIS

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编55413

电话16123798854

网址https://www.bio-techne.com/

公司代码TECH

上市日期Feb 09, 1989

CEOKelderman (Kim)

Bio-Techne Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. John L. Higgins

Independent Director

66.88K

+1640.00%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

48.66K

-2303.00%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+1640.00%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+1640.00%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+1640.00%

Ms. Julie L. Bushman

Independent Director

8.78K

+1640.00%

Mr. Shane Bohnen

Senior Vice President, General Counsel, Corporate Secretary

4.38K

Dr. Judith V. Klimovsky, M.D.

Independent Director

3.78K

+1640.00%

Mr. James T. (Jim) Hippel

Chief Financial Officer, Executive Vice President - Finance

Mr. David Clair

Investor Relations

名称

名称/职务

职务

持股

持股变动

Mr. John L. Higgins

Independent Director

66.88K

+1640.00%

Mr. Kim Kelderman

President, Chief Executive Officer, Director

48.66K

-2303.00%

Mr. Robert V. (Bob) Baumgartner, CPA

Independent Chairman of the Board

46.50K

+1640.00%

Dr. Joseph D. (Joe) Keegan, Ph.D.

Independent Director

15.41K

+1640.00%

Dr. Rupert J. Vessey, Ph.D.

Independent Director

10.99K

+1640.00%

Ms. Julie L. Bushman

Independent Director

8.78K

+1640.00%

收入明细

单位: USD更新时间: 1月6日周二

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Consumables

231.60M

80.82%

Service

27.48M

9.59%

Instruments

21.83M

7.62%

Royalty

5.65M

1.97%

地区USD

名称

营收

占比

United States

155.24M

54.17%

EMEA, excluding U.K

65.13M

22.73%

Greater China

24.79M

8.65%

APAC, excluding Greater China

19.15M

6.68%

United Kingdom

13.21M

4.61%

Rest of World

9.05M

3.16%

业务

地区

业务USD

名称

营收

占比

Consumables

231.60M

80.82%

Service

27.48M

9.59%

Instruments

21.83M

7.62%

Royalty

5.65M

1.97%

股东统计

更新时间: 11月16日周日

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

11.48%

BlackRock Institutional Trust Company, N.A.

5.64%

State Street Investment Management (US)

3.69%

Wellington Management Company, LLP

3.28%

Atlanta Capital Management Company, L.L.C.

3.17%

其他

72.73%

持股股东

占比

The Vanguard Group, Inc.

11.48%

BlackRock Institutional Trust Company, N.A.

5.64%

State Street Investment Management (US)

3.69%

Wellington Management Company, LLP

3.28%

Atlanta Capital Management Company, L.L.C.

3.17%

其他

72.73%

股东类型

持股股东

占比

Investment Advisor

58.57%

Investment Advisor/Hedge Fund

34.00%

Hedge Fund

8.06%

Bank and Trust

2.18%

Research Firm

1.96%

Pension Fund

1.35%

Sovereign Wealth Fund

1.24%

Individual Investor

0.28%

Insurance Company

0.24%

机构持股



更新时间: 1月1日周四

报告期

机构数

持股数

持股占比

持股变动

2025Q4

1201

167.79M

107.68%

+389.22K

2025Q3

1198

161.18M

103.53%

-7.34M

2025Q2

1209

165.25M

105.41%

-730.33K

2025Q1

1245

168.10M

107.22%

+1.54M

2024Q4

1233

162.21M

102.61%

-6.39M

2024Q3

1205

159.40M

100.49%

-10.21M

2024Q2

1207

160.52M

101.86%

-12.24M

2024Q1

1216

162.56M

103.40%

-7.57M

2023Q4

1229

159.70M

100.98%

-3.97M

2023Q3

1217

156.41M

98.84%

-7.93M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

17.89M

11.48%

-504.17K

-2.74%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

8.79M

5.64%

-7.47K

-0.08%

Sep 30, 2025

State Street Investment Management (US)

5.75M

3.69%

-105.19K

-1.80%

Sep 30, 2025

Wellington Management Company, LLP

5.12M

3.28%

+3.98M

+349.84%

Sep 30, 2025

Atlanta Capital Management Company, L.L.C.

4.94M

3.17%

+646.77K

+15.06%

Sep 30, 2025

Geode Capital Management, L.L.C.

4.93M

3.16%

+864.67K

+21.28%

Sep 30, 2025

Invesco Capital Management LLC

3.51M

2.26%

+275.06K

+8.49%

Sep 30, 2025

Neuberger Berman, LLC

3.31M

2.12%

+807.15K

+32.29%

Sep 30, 2025

T. Rowe Price Associates, Inc.

3.12M

-5.50M

-63.78%

Sep 30, 2025

Maverick Capital, Ltd.

3.01M

1.93%

+3.01M

Sep 30, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

Global X Genomics & Biotechnology ETF

4.29%

Invesco Biotechnology & Genome ETF

2.92%

Invesco S&P 500 Equal Weight Health Care ETF

Neuberger Berman Small-Mid Cap ETF

1.78%

VanEck Biotech ETF

1.73%

Hilton Small-MidCap Opportunity ETF

1.7%

iShares Health Innovation Active ETF

1.68%

American Century Mid Cap Growth Impact ETF

1.47%

Thrivent Small-Mid Cap ESG ETF

1.34%

Invesco S&P 500 High Beta ETF

1.06%

Global X Genomics & Biotechnology ETF

占比4.29%

Invesco Biotechnology & Genome ETF

占比2.92%

Invesco S&P 500 Equal Weight Health Care ETF

占比2%

Neuberger Berman Small-Mid Cap ETF

占比1.78%

VanEck Biotech ETF

占比1.73%

Hilton Small-MidCap Opportunity ETF

占比1.7%

iShares Health Innovation Active ETF

占比1.68%

American Century Mid Cap Growth Impact ETF

占比1.47%

Thrivent Small-Mid Cap ESG ETF

占比1.34%

Invesco S&P 500 High Beta ETF

占比1.06%

分红派息



近5年累计派现 250.90M 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

Nov 05, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 28, 2025 going ex on Nov 17, 2025

Nov 17, 2025

Nov 28, 2025

Nov 17, 2025

Aug 06, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 29, 2025 going ex on Aug 18, 2025

Aug 18, 2025

Aug 29, 2025

Aug 18, 2025

May 07, 2025

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 30, 2025 going ex on May 19, 2025

May 19, 2025

May 30, 2025

May 19, 2025

Feb 05, 2025

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 17, 2025

Feb 28, 2025

Feb 14, 2025

Oct 30, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 22, 2024 going ex on Nov 08, 2024

Nov 11, 2024

Nov 22, 2024

Nov 08, 2024

Aug 07, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Aug 30, 2024 going ex on Aug 19, 2024

Aug 19, 2024

Aug 30, 2024

Aug 19, 2024

May 01, 2024

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on May 24, 2024 going ex on May 10, 2024

May 13, 2024

May 24, 2024

May 10, 2024

Feb 01, 2024

TECH.NB Final Cash Dividend of gross USD 0.08 paid on Feb 26, 2024 going ex on Feb 09, 2024

Feb 12, 2024

Feb 26, 2024

Feb 09, 2024

Oct 31, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Nov 24, 2023 going ex on Nov 09, 2023

Nov 10, 2023

Nov 24, 2023

Nov 09, 2023

Aug 08, 2023

TECH.NB Interim Cash Dividend of gross USD 0.08 paid on Sep 01, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 01, 2023

Aug 17, 2023

拆合股



公告日期

类型

比率

Nov 01, 2022

Split

1→4

公告日期

类型

比率

Nov 01, 2022

Split

1→4

常见问题

Bio-Techne Corp的前五大股东是谁？



Bio-Techne Corp 的前五大股东如下：
The Vanguard Group, Inc.持有股份：17.89M，占总股份比例：11.48%。
BlackRock Institutional Trust Company, N.A.持有股份：8.79M，占总股份比例：5.64%。
State Street Investment Management (US)持有股份：5.75M，占总股份比例：3.69%。
Wellington Management Company, LLP持有股份：5.12M，占总股份比例：3.28%。
Atlanta Capital Management Company, L.L.C.持有股份：4.94M，占总股份比例：3.17%。